Skip to search formSkip to main contentSkip to account menu

dihydroxybutyl ether

Known as: 4,4'-oxybis-2-butanol, 4,4'-oxydi-2-butanol, dihydroxydibutylether 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Ethers

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
Chemoprevention by antineoplaston A10 of benzo(a)pyrene-induced pulmonary neoplasia.
The effect of Antineoplaston A10 (AA10), an amino acid derivative isolated from human urine, has been studied on pulmonary… 
1987
1987
Intrahepatic cholestasis in acute viral hepatitis: a double-blind trial with dihydroxydibutylether in comparison with placebo.
The authors studied the effectiveness of a choleretic drug, dihydroxydibutylether (DHBE), 900 mg daily, in patients with acute… 
1983
1983
A double-blind comparative trial of dihydroxydibutylether in patients with cholesterol gallstones.
In a double-blind crossover design we compared dihydroxydibutylether (DHBE) with placebo in ten patients with cholesterol… 
1983
1983
The effect of dihydroxydibutylether on bile lipid composition in patients with gallstones.
Dihydroxydibutylether (DHBE, 900 mg/day, in divided doses) was given to 13 patients with radiolucent gallstones. Bile lipid… 
1981
1981
Effect of dihydroxydibutylether on the lithogenic index of patients with cholesterol gallstones.
Daily administration of 900 mg dihydroxydibutylether (DHBE) produced a significant reduction of lithogenic index in patients with… 
1980
1980
Preliminary results on the action of dihydroxydibutylether on the lithogenic index of patients with calculosis of the gall-bladder.
Oral administration of 900 mg daily of dihydroxydibutylether to patients with cholesterol stones in the gall-bladder, reduced the…